跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Allogeneic cord blood
首页
药物
Allogeneic cord blood
Allogeneic cord blood
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Cord blood banks and uses thereof
申请人: STICHTING EUROCORD NEDERLAND
优先权: 2001
EP
Pharmaceutical composition for blood cell recovery after umbilical cord blood transplantation
申请人: UNIV TSUKUBA
优先权: 2022
CN
Universal donor checkpoint inhibitor silenced/gene edited cord blood killer cells
申请人: REGEN BIOPHARMA INC
优先权: 2017
US
METHOD FOR PRODUCING CORD BLOOD-DERIVED MYELOID-DERIVED SUPPRESSOR CELLS FROM HUMAN CORD BLOOD CD34+ CELLS, CORD BLOOD-DERIVED MYELOID-DERIVED SUPPRESSOR CELLS PRODUCED BY SAME PRODUCTION METHOD, AND PHARMACEUTICAL USE THEREOF
申请人: VIGENCELL INC
优先权: 2024
WO
Cell-free allosome exosome formulations and methods of use thereof
申请人: NEUROCYTE B V
优先权: 2022
CN
METHODS FOR ISOLATION OF PLATELETS
申请人: ANTHROGENESIS CORP
优先权: 2014
CN
EP
US
WO
4 件公开
Human cord blood as a source of neural tissue for repair of the brain and spinal cord
申请人: UNIV SOUTH FLORIDA
优先权: 2001
US
5 件公开
Method for improving endometriosis by applying stem cell therapy
申请人: CAR T SHANGHAI BIOTECHNOLOGY CO LTD
优先权: 2020
CN
药物
反馈